Patient characteristics | Infracolic group (nā=ā53) | Infragastric group (nā=ā53) | P value | Ā |
---|---|---|---|---|
Age, meanāĀ±āSD (year) | 51.5āĀ±ā9.8 | 48.1āĀ±ā8.6 | 0.058* | Ā |
BMI, median [quartile] (kg/m2) | 22.1[19.9ā24.6] | 21.2[20.0-23.5] | 0.446ā” | Ā |
CA125, n(%) | Ā | Ā | 0.151ā | Ā |
ā<35U/ml | 14(26.4) | 8(15.1) | Ā | Ā |
āā„35U/ml | 39(73.6) | 45(84.9) | Ā | Ā |
Surgical procedure, n (%) | Ā | Ā | 0.587ā | Ā |
āLaparoscopy | 46(86.8) | 44(83.0) | Ā | Ā |
āLaparotomy | 7(13.2) | 9(17.0) | Ā | Ā |
Ascites, n (%) | Ā | Ā | 0.119ā | Ā |
āNo | 33(62.3) | 25(47.2) | Ā | Ā |
āYes | 20(33.7) | 28(52.8) | Ā | Ā |
Intraoperative stage, n (%) | Ā | Ā | 0.625ā | Ā |
āI | 29(54.7) | 27(50.9) | Ā | Ā |
āII | 15(28.3) | 13(24.5) | Ā | Ā |
āIII | 9(17.0) | 13(24.5) | Ā | Ā |
Cytology, n (%) | Ā | Ā | 0.169ā | Ā |
āNegative | 34(64.2) | 27(50.9) | Ā | Ā |
āPositive | 19(35.8) | 26(49.1) | Ā | Ā |
Final stage, n (%) | Ā | Ā | 0.351ā | Ā |
āI | 27(50.9) | 22 (41.5) | Ā | Ā |
āII | 12(22.6) | 10(18.9) | Ā | Ā |
āIII | 14(26.4) | 21(39.6) | Ā | Ā |
Histologic type, n (%) | Ā | Ā | Ā | Ā |
āHigh-grade serous | 29(54.7) | 30(56.6) | 0.845ā | Ā |
āLow-grade serous | 1(5.3) | 1(5.3) | Ā | Ā |
āClear cell | 8(15.1) | 8(15.1) | Ā | Ā |
āEndometrioid | 8(15.1) | 4(7.5) | Ā | Ā |
āMucinous | 4(7.5) | 10(18.9) | Ā | Ā |
āOthers | 3(5.7) | 0(0) | Ā | Ā |
Omentum involvement, n (%) | Ā | Ā | 0.005ā | Ā |
āYes | 4(7.5) | 15(28.3) | Ā | |
āNo | 49(92.5) | 38(71.7) | Ā | Ā |
Lymphatic involvement, n (%) | Ā | Ā | 0.780ā | |
āYes | 7(13.2) | 8(15.1) | Ā | Ā |
āNo | 46(86.8) | 45(84.9) | Ā |